222 related articles for article (PubMed ID: 8050525)
1. The effects of antimalarials on the Plasmodium falciparum dihydroorotate dehydrogenase.
Ittarat I; Asawamahasakda W; Meshnick SR
Exp Parasitol; 1994 Aug; 79(1):50-6. PubMed ID: 8050525
[TBL] [Abstract][Full Text] [Related]
2. High-performance liquid chromatographic determination of dihydroorotate dehydrogenase of Plasmodium falciparum and effects of antimalarials on enzyme activity.
Ittarat I; Webster HK; Yuthavong Y
J Chromatogr; 1992 Nov; 582(1-2):57-64. PubMed ID: 1491058
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum.
Seymour KK; Lyons SD; Phillips L; Rieckmann KH; Christopherson RI
Biochemistry; 1994 May; 33(17):5268-74. PubMed ID: 7909690
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria.
Hoelz LV; Calil FA; Nonato MC; Pinheiro LC; Boechat N
Future Med Chem; 2018 Aug; 10(15):1853-1874. PubMed ID: 30019917
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of potent inhibitors of the malaria parasite dihydroorotate dehydrogenase.
Heikkilä T; Ramsey C; Davies M; Galtier C; Stead AM; Johnson AP; Fishwick CW; Boa AN; McConkey GA
J Med Chem; 2007 Jan; 50(2):186-91. PubMed ID: 17228860
[TBL] [Abstract][Full Text] [Related]
6. Novel inhibitors of the Plasmodium falciparum electron transport chain.
Stocks PA; Barton V; Antoine T; Biagini GA; Ward SA; O'Neill PM
Parasitology; 2014 Jan; 141(1):50-65. PubMed ID: 24401337
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 7-arylaminopyrazolo[1,5-a]pyrimidines as anti-Plasmodium falciparum, antimalarial, and Pf-dihydroorotate dehydrogenase inhibitors.
Azeredo LFSP; Coutinho JP; Jabor VAP; Feliciano PR; Nonato MC; Kaiser CR; Menezes CMS; Hammes ASO; Caffarena ER; Hoelz LVB; de Souza NB; Pereira GAN; Cerávolo IP; Krettli AU; Boechat N
Eur J Med Chem; 2017 Jan; 126():72-83. PubMed ID: 27744189
[TBL] [Abstract][Full Text] [Related]
8. dCTP levels are maintained in Plasmodium falciparum subjected to pyrimidine deficiency or excess.
Seymour KK; Yeo AE; Rieckmann KH; Christopherson RI
Ann Trop Med Parasitol; 1997 Sep; 91(6):603-9. PubMed ID: 9425362
[TBL] [Abstract][Full Text] [Related]
9. Purification, characterization and localization of mitochondrial dihydroorotate dehydrogenase in Plasmodium falciparum, human malaria parasite.
Krungkrai J
Biochim Biophys Acta; 1995 Apr; 1243(3):351-60. PubMed ID: 7727509
[TBL] [Abstract][Full Text] [Related]
10. Dihydroorotate dehydrogenase: A drug target for the development of antimalarials.
Singh A; Maqbool M; Mobashir M; Hoda N
Eur J Med Chem; 2017 Jan; 125():640-651. PubMed ID: 27721149
[TBL] [Abstract][Full Text] [Related]
11. Identification of 3,4-Dihydro-2
Hartuti ED; Sakura T; Tagod MSO; Yoshida E; Wang X; Mochizuki K; Acharjee R; Matsuo Y; Tokumasu F; Mori M; Waluyo D; Shiomi K; Nozaki T; Hamano S; Shiba T; Kita K; Inaoka DK
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281290
[No Abstract] [Full Text] [Related]
12. Atovaquone tolerance in Plasmodium falciparum parasites selected for high-level resistance to a dihydroorotate dehydrogenase inhibitor.
Guler JL; White J; Phillips MA; Rathod PK
Antimicrob Agents Chemother; 2015 Jan; 59(1):686-9. PubMed ID: 25331708
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial activity of orotate analogs that inhibit dihydroorotase and dihydroorotate dehydrogenase.
Krungkrai J; Krungkrai SR; Phakanont K
Biochem Pharmacol; 1992 Mar; 43(6):1295-301. PubMed ID: 1348618
[TBL] [Abstract][Full Text] [Related]
14. QSAR study on the antimalarial activity of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors.
Hou X; Chen X; Zhang M; Yan A
SAR QSAR Environ Res; 2016; 27(2):101-24. PubMed ID: 26911561
[TBL] [Abstract][Full Text] [Related]
15. Identification of inhibitors that dually target the new permeability pathway and dihydroorotate dehydrogenase in the blood stage of Plasmodium falciparum.
Dickerman BK; Elsworth B; Cobbold SA; Nie CQ; McConville MJ; Crabb BS; Gilson PR
Sci Rep; 2016 Nov; 6():37502. PubMed ID: 27874068
[TBL] [Abstract][Full Text] [Related]
16. Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum.
Phillips MA; Gujjar R; Malmquist NA; White J; El Mazouni F; Baldwin J; Rathod PK
J Med Chem; 2008 Jun; 51(12):3649-53. PubMed ID: 18522386
[TBL] [Abstract][Full Text] [Related]
17. The first de novo designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
Heikkilä T; Thirumalairajan S; Davies M; Parsons MR; McConkey AG; Fishwick CW; Johnson AP
Bioorg Med Chem Lett; 2006 Jan; 16(1):88-92. PubMed ID: 16236496
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of small molecule inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
Patel V; Booker M; Kramer M; Ross L; Celatka CA; Kennedy LM; Dvorin JD; Duraisingh MT; Sliz P; Wirth DF; Clardy J
J Biol Chem; 2008 Dec; 283(50):35078-85. PubMed ID: 18842591
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo.
Krugliak M; Deharo E; Shalmiev G; Sauvain M; Moretti C; Ginsburg H
Exp Parasitol; 1995 Aug; 81(1):97-105. PubMed ID: 7628573
[TBL] [Abstract][Full Text] [Related]
20. The chemotherapy of rodent malaria, XXXVIII. Studies on the activity of three new antimalarials (WR 194,965, WR 228,258 and WR 225,448) against rodent and human malaria parasites (Plasmodium berghei and P. falciparum).
Peters W; Irare SG; Ellis DS; Warhurst DC; Robinson BL
Ann Trop Med Parasitol; 1984 Dec; 78(6):567-79. PubMed ID: 6398032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
